CliffBio
small molecule

CITALOPRAM HYDROBROMIDE

CITALOPRAM HYDROBROMIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameCITALOPRAM HYDROBROMIDE
Active ingredientCITALOPRAM HYDROBROMIDE
StrengthEQ 10MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2004
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.